Search research articles
Contact Us
Filters
Showing results (501-510 of 548) with videos related to
Page
of 55
Sort By:
Blood
|
January 17, 2012
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
Jennifer A Dumont, Tongyao Liu, Susan C Low, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 27, 2007
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene
Lingxia Chen, Fuxiang Zhu, Juan Li, et al.
Vaccines
|
June 27, 2025
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals
Jonathan Kitonsa, Jennifer Serwanga, Hannah M Cheeseman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 22, 2024
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results
Cedric Hermans, Leonard A Valentino, Courtney D Thornburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2025
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
Mirat Shah, Ting-Yu Chen, Gwynn Ison, et al.
Blood
|
March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B
Valder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2020
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, et al.
Nature Medicine
|
September 17, 2013
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A
Gouri Shankar Pandey, Chen Yanover, Lisa M Miller-Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2022
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2022
FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation
Sandra J Casak, Shan Pradhan, Lola A Fashoyin-Aje, et al.
Page
of 55
Search research articles
Search
Showing results (501-510 of 548) with videos related to
Sort By:
Page
of 55
Blood
|
January 17, 2012
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
Jennifer A Dumont, Tongyao Liu, Susan C Low, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 27, 2007
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene
Lingxia Chen, Fuxiang Zhu, Juan Li, et al.
Vaccines
|
June 27, 2025
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals
Jonathan Kitonsa, Jennifer Serwanga, Hannah M Cheeseman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 22, 2024
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results
Cedric Hermans, Leonard A Valentino, Courtney D Thornburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2025
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
Mirat Shah, Ting-Yu Chen, Gwynn Ison, et al.
Blood
|
March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B
Valder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2020
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, et al.
Nature Medicine
|
September 17, 2013
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A
Gouri Shankar Pandey, Chen Yanover, Lisa M Miller-Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2022
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2022
FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation
Sandra J Casak, Shan Pradhan, Lola A Fashoyin-Aje, et al.
Page
of 55